» Articles » PMID: 20392703

Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People

Abstract

The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics-European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as 'presarcopenia', 'sarcopenia' and 'severe sarcopenia'. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.

Citing Articles

Oxidative balance score is associated with increased risk of sarcopenia and sarcopenic obesity in non-elderly adults: results from NHANES 2011-2018.

Wang Z, Xu Q, Zhang Y, Wu R, Cui J, Zhou J Nutr Metab (Lond). 2025; 22(1):23.

PMID: 40069772 PMC: 11899308. DOI: 10.1186/s12986-025-00914-3.


The influencing factors of tumor-related sarcopenia: a scoping review.

Tian C, Li N, Gao Y, Yan Y BMC Cancer. 2025; 25(1):426.

PMID: 40065271 PMC: 11892265. DOI: 10.1186/s12885-025-13837-2.


Assessment of sarcopenia in young patients with inflammatory arthritis: a cross-sectional study.

Kulyk M, Dzhus M Sci Rep. 2025; 15(1):8236.

PMID: 40064969 PMC: 11893876. DOI: 10.1038/s41598-025-88939-9.


Chronic treatment of old mice with AICAR reverses age-related changes in exercise performance and skeletal muscle gene expression.

Wilcox S, Calixto J, Dray S, Rasch D, Smith A, Brodowski K FASEB Bioadv. 2025; 7(3):e1491.

PMID: 40060947 PMC: 11886611. DOI: 10.1096/fba.2024-00252.


The evidence and impact of deprescribing on sarcopenia parameters: a systematic review.

Ibrahim K, Cox N, Lim S, Radcliffe E, Lundby C, Prokopidis K BMC Geriatr. 2025; 25(1):158.

PMID: 40055633 PMC: 11887267. DOI: 10.1186/s12877-025-05819-7.


References
1.
Janssen I, Baumgartner R, Ross R, Rosenberg I, Roubenoff R . Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004; 159(4):413-21. DOI: 10.1093/aje/kwh058. View

2.
Sayer A, Dennison E, Syddall H, Gilbody H, Phillips D, Cooper C . Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg?. Diabetes Care. 2005; 28(10):2541-2. DOI: 10.2337/diacare.28.10.2541. View

3.
Muscaritoli M, Anker S, Argiles J, Aversa Z, Bauer J, Biolo G . Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29(2):154-9. DOI: 10.1016/j.clnu.2009.12.004. View

4.
Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield S, Ross R . Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8):755-63. DOI: 10.1093/oxfordjournals.aje.a009520. View

5.
Morley J, Baumgartner R, Roubenoff R, Mayer J, Nair K . Sarcopenia. J Lab Clin Med. 2001; 137(4):231-43. DOI: 10.1067/mlc.2001.113504. View